22
Jul
2011
Posted in I - Series B, Q - 2Q11, R - NORTH EAST, X - Incontinence, X - Inflammation, X - Oncology, XX - MA
Taris Biomedical (Lexington, MA) a clinical-stage specialty pharmaceutical company focused on bladder diseases in pain, inflammation, oncology and incontinence, closed a $18.3M Series B financing. Participants include Third Rock Ventures, Flagship Ventures, Flybridge Capital Partners and Polaris Venture Partners.
26
Apr
2009